Antibiomania: a case report of clarithromycin and amoxicillin-clavulanic acid induced manic episodes separately

Edith Paula Meszaros1, Catheline Stancu2, Alessandra Costanza2

  • 1Departments of Emergency and Psychiatry, Emergency Psychiatric Unit (UAUP), Geneva University Hospitals (HUG), Geneva, Switzerland. meszaros.edith.paula@gmail.com.

BMC Psychiatry
|August 12, 2021
PubMed
Abstract

Insights

This case report highlights antibiomania, a rare side effect of antibiotics. A patient experienced a manic episode linked to clarithromycin and amoxicillin-clavulanic acid, emphasizing potential drug interactions.

Area of Science:

  • Pharmacology
  • Psychiatry
  • Infectious Diseases

Background:

  • Antibiomania is a rare adverse effect of antibiotic therapy with an unclear pathogenesis.
  • This case explores a potential pharmacodynamic drug-drug interaction between clarithromycin and amoxicillin-clavulanic acid.

Observation:

  • A 50-year-old male with no prior psychiatric history developed a manic episode after initiating amoxicillin-clavulanic acid, followed by clarithromycin for pneumonia.
  • Symptoms included logorrhea, elevated mood, irritability, increased activity, and delusions, resolving upon clarithromycin discontinuation and reappearing with amoxicillin-clavulanic acid reintroduction.

Findings:

  • The patient's symptoms strongly suggest a clarithromycin-induced manic episode, potentially exacerbated by amoxicillin-clavulanic acid.
  • Cessation of clarithromycin led to symptom amelioration within 12 hours, and complete resolution occurred after stopping amoxicillin-clavulanic acid.

Implications:

  • Early recognition of antibiotic-induced psychiatric side effects is crucial for patient care and recovery.
  • This case serves as a clinical reminder of potential interactions and adverse psychiatric effects associated with common antibiotic combinations.

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
376
Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
199
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
34
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
486
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
294
Cholinergic Antagonists: Pharmacokinetics01:24

Cholinergic Antagonists: Pharmacokinetics

Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations,  while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
620